Nivolumab (Anti-PD1), Tadalafil and Oral Vancomycin in People With Refractory Primary Hepatocellular Carcinoma or Liver Dominant Metastatic Cancer From Colorectal or Pancreatic Cancers
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Mayo Clinic
Takeda
Baylor College of Medicine
HistoSonics, Inc.
Stanford University
HistoSonics, Inc.
University of Southern California
University of Washington
Massachusetts General Hospital
National Institutes of Health Clinical Center (CC)
Thomas Jefferson University
Federation Francophone de Cancerologie Digestive
Bayer
Thomas Jefferson University